|
Mar 6
|
How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%
|
|
Mar 5
|
Tarsus to Participate at Upcoming Investor Conferences
|
|
Mar 5
|
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
|
|
Dec 11
|
Tarsus Announces Positive Topline Results from the Ersa Phase 2a Clinical Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease in Patients with Demodex Mites
|
|
Dec 2
|
Insider Sell Alert: Tarsus Pharmaceuticals Inc's Dianne Whitfield Offloads 8,355 Shares
|
|
Aug 30
|
Tarsus to Present at Upcoming Investor Conferences
|
|
Aug 28
|
15 Most Shorted Stocks That Are Loved By Analysts
|